Cellsonics
Founded 2017 · 3 known investors
CellSonics develops SimpleFlow, an instrument that uses acoustic waves rather than enzymes to dissociate tissue into single cells, aiming to release more cells without bias. It is used in life sciences applications such as single-cell RNA sequencing, demonstrated on mouse brain tissue with higher preservation of astrocytes and neurons.
BiotechHardwareMedical Devices
Investors · 3
Frequently asked questions
- What does Cellsonics do?
- CellSonics develops SimpleFlow, an instrument that uses acoustic waves rather than enzymes to dissociate tissue into single cells, aiming to release more cells without bias. It is used in life sciences applications such as single-cell RNA sequencing, demonstrated on mouse brain tissue with higher preservation of astrocytes and neurons.
- Who are Cellsonics's investors?
- Cellsonics's investors include OMX Ventures, Vertical Venture Partners, Wavemaker Three-Sixty Health.